Syndax Pharmaceuticals Inc (SNDX)
15.60
-0.35
(-2.19%)
USD |
NASDAQ |
Nov 21, 16:00
15.59
-0.01
(-0.06%)
After-Hours: 20:00
Syndax Pharmaceuticals Market Cap: 1.332B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 1.332B |
| November 20, 2024 | 1.361B |
| November 19, 2024 | 1.346B |
| November 18, 2024 | 1.375B |
| November 15, 2024 | 1.351B |
| November 14, 2024 | 1.433B |
| November 13, 2024 | 1.419B |
| November 12, 2024 | 1.384B |
| November 11, 2024 | 1.859B |
| November 08, 2024 | 1.862B |
| November 07, 2024 | 1.837B |
| November 06, 2024 | 1.822B |
| November 05, 2024 | 1.681B |
| November 04, 2024 | 1.617B |
| November 01, 2024 | 1.620B |
| October 31, 2024 | 1.608B |
| October 30, 2024 | 1.614B |
| October 29, 2024 | 1.627B |
| October 28, 2024 | 1.638B |
| October 25, 2024 | 1.599B |
| October 24, 2024 | 1.620B |
| October 23, 2024 | 1.581B |
| October 22, 2024 | 1.634B |
| October 21, 2024 | 1.666B |
| October 18, 2024 | 1.681B |
| Date | Value |
|---|---|
| October 17, 2024 | 1.696B |
| October 16, 2024 | 1.696B |
| October 15, 2024 | 1.684B |
| October 14, 2024 | 1.690B |
| October 11, 2024 | 1.632B |
| October 10, 2024 | 1.552B |
| October 09, 2024 | 1.562B |
| October 08, 2024 | 1.568B |
| October 07, 2024 | 1.557B |
| October 04, 2024 | 1.605B |
| October 03, 2024 | 1.594B |
| October 02, 2024 | 1.658B |
| October 01, 2024 | 1.696B |
| September 30, 2024 | 1.642B |
| September 27, 2024 | 1.607B |
| September 26, 2024 | 1.545B |
| September 25, 2024 | 1.533B |
| September 24, 2024 | 1.556B |
| September 23, 2024 | 1.526B |
| September 20, 2024 | 1.555B |
| September 19, 2024 | 1.585B |
| September 18, 2024 | 1.532B |
| September 17, 2024 | 1.537B |
| September 16, 2024 | 1.549B |
| September 13, 2024 | 1.627B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
180.48M
Minimum
Jan 29 2020
2.110B
Maximum
Jul 16 2024
1.126B
Average
1.074B
Median
Market Cap Benchmarks
| Vertex Pharmaceuticals Inc | 115.98B |
| Moderna Inc | 14.72B |
| NovaBay Pharmaceuticals Inc | 3.517M |
| Palatin Technologies Inc | 18.35M |
| iBio Inc | 22.42M |
Market Cap Related Metrics
| PEG Ratio | -0.1056 |
| Price to Book Value | 3.634 |
| Price | 15.60 |
| Earnings Yield | -23.27% |
| PEGY Ratio | -0.1056 |